Precision Biosciences (DTIL) Prepaid Assets (2018 - 2026)
Precision Biosciences' (DTIL) quarterly Prepaid Assets came in at $6000.0 in Q1 2026, down 99.87% year-on-year from $4.6 million in Q1 2025, and down 99.81% on a QoQ basis from $3.1 million in Q4 2025.
Precision Biosciences (DTIL) Prepaid Assets (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Prepaid Assets data on file, last reported at $6000.0 in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 99.87% year-over-year to $6000.0 in Q1 2026; TTM through Mar 2026 was $6000.0, a 99.87% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 51.72% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6000.0, down from $3.1 million in the prior quarter.
- Over the last five years, Prepaid Assets for DTIL reached as high as $17.1 million in Q1 2022 and fell as low as $6000.0 in Q1 2026.
- Historically, Prepaid Assets has averaged $5.2 million across 5 years, with a median of $4.6 million in 2025.
- Across the five-year window, Prepaid Assets soared 48642.86% in 2022 and sank 99.87% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $6.0 million in 2022, then slipped by 0.8% to $6.0 million in 2023, then advanced by 7.76% to $6.4 million in 2024, then slumped by 51.72% to $3.1 million in 2025, then slumped by 99.81% to $6000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $6000.0 in Q1 2026, $3.1 million in Q4 2025, and $848000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 848,000.00 |
| Jun 30, 2025 | 427,000.00 |
| Mar 31, 2025 | 4.59 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | 471,000.00 |
| Jun 30, 2024 | 790,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | 8.08 Mn |
| Jun 30, 2023 | 503,000.00 |
| Mar 31, 2023 | 8.42 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 12.29 Mn |
| Jun 30, 2022 | 12.63 Mn |
| Mar 31, 2022 | 17.06 Mn |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 5.42 Mn |